Bronchodilator therapy for chronic obstructive pulmonary disease

Respirology

Volumn 2, Issue 4, 1997, Pages 317-322

  Lu, Chong Chen ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Acute exacerbation; Bronchodilator therapy; Chronic obstructive pulmonary disease; Combination therapy; Inhalation technique

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE; THEOPHYLLINE DERIVATIVE;

AIRWAY DYNAMICS; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; METERED DOSE INHALER; NEBULIZATION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0031410818     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.1997.tb00096.x     Document Type: Article

References (4)

1. Snider GL. Chronic obstructive pulmonary disease: A definition and implications of structural determinants of airflow obstruction for epidermiology. Am. Rev. Respir. Dis. 1989; 140: (Suppl 3): 3-8.
2. American Thoracic Society, Medical Section of the American Lung Association. Standard for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 1987; 136: 225-44.
3. Thom TJ. International comparisons in COPD mortality. Am. Rev. Respir. Dis. 1989; 140: S27-34.
4. Feinlieb M, Rosenberg HM, Collins JG, Delozier JE, Pokras R, Chevarley FM. Trends in COPD morbidity and mortality in the United States. Am. Rev. Respir. Dis. 1989; 140: S9-18.